{"nct_id":"NCT01523171","title":"Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib","status":"COMPLETED","status_verified_date":"2016-02","start_date":"2012-04","start_date_type":null,"primary_completion_date":"2014-04","primary_completion_date_type":"ACTUAL","completion_date":"2014-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}